DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Stock

Certificat

DE000MG1C9X6

Real-time Bid/Ask 11:13:54 2024-07-03 EDT
113.12 EUR / 113.15 EUR -1.96% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.59%
1 month+4.03%
Date Price Change
24-07-03 114.6 -0.68%
24-07-02 115.4 -1.08%
24-07-01 116.7 +0.50%
24-06-28 116.1 -0.07%
24-06-27 116.2 -0.20%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 06:36 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN MG1C9X
ISINDE000MG1C9X6
Date issued 2024-04-02
Cap 140 $
Last trading day 2025-03-21
Maturity 2025-03-21 (261 Days)
Parity 1 : 1
Emission price 106.6
Emission volume N/A
Payment day 2025-03-28
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 11.81 %
Sideways yield 13.42 %
Sideways yield pa 18.77 %
Outperformance point 158.8 $
Break even 122.18 €
Highest since issue 116.7
Lowest since issue 103.4
Spread 0.05
Spread %0.04%
Distance Cap -2.26 $
Distance Cap %-1.64%
Max. earning 16.5
Max. earning % 14.59 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus